USA Anti-PD-1 Antibody Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Anti-PD-1 Antibody market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Anti-PD-1 Antibody market. Detailed analysis of key players, along with key growth strategies adopted by Anti-PD-1 Antibody industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • BioVision Inc

    • Bio X Cell

    • Bristol-Myers Squibb (BMS)

    • Chugai Pharmaceutical Co, Ltd

    • Arcus Biosciences

    • Abbvie

    • Ono Pharmaceutical Co, Ltd

    • Sino Biological Inc

    • Merck

    • Abcam

    • BeiGene

    • TG Therapeutics, Inc

    • InvivoGen

    • 3SBio Inc

    • Novartis

    • Thermo Fisher

    • Lilly

    By Type:

    • Monoclonal

    • Polyclonal

    By End-User:

    • IHC-P

    • ICC/IF

    • WB

    • Flow Cytometry

    • ELISA

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-PD-1 Antibody Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Anti-PD-1 Antibody Market Size and Growth Rate of Monoclonal from 2016 to 2027

      • 1.3.2 USA Anti-PD-1 Antibody Market Size and Growth Rate of Polyclonal from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Anti-PD-1 Antibody Market Size and Growth Rate of IHC-P from 2016 to 2027

      • 1.4.2 USA Anti-PD-1 Antibody Market Size and Growth Rate of ICC/IF from 2016 to 2027

      • 1.4.3 USA Anti-PD-1 Antibody Market Size and Growth Rate of WB from 2016 to 2027

      • 1.4.4 USA Anti-PD-1 Antibody Market Size and Growth Rate of Flow Cytometry from 2016 to 2027

      • 1.4.5 USA Anti-PD-1 Antibody Market Size and Growth Rate of ELISA from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Anti-PD-1 Antibody Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Anti-PD-1 Antibody Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Anti-PD-1 Antibody Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Anti-PD-1 Antibody Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Anti-PD-1 Antibody Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Anti-PD-1 Antibody by Major Types

      • 3.4.1 Market Size and Growth Rate of Monoclonal

      • 3.4.2 Market Size and Growth Rate of Polyclonal

    4 Segmentation of Anti-PD-1 Antibody Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Anti-PD-1 Antibody by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Anti-PD-1 Antibody in IHC-P

      • 4.4.2 Market Size and Growth Rate of Anti-PD-1 Antibody in ICC/IF

      • 4.4.3 Market Size and Growth Rate of Anti-PD-1 Antibody in WB

      • 4.4.4 Market Size and Growth Rate of Anti-PD-1 Antibody in Flow Cytometry

      • 4.4.5 Market Size and Growth Rate of Anti-PD-1 Antibody in ELISA

    5 Market Analysis by Regions

    • 5.1 USA Anti-PD-1 Antibody Production Analysis by Regions

    • 5.2 USA Anti-PD-1 Antibody Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Anti-PD-1 Antibody Landscape Analysis

    • 6.1 West USA Anti-PD-1 Antibody Landscape Analysis by Major Types

    • 6.2 West USA Anti-PD-1 Antibody Landscape Analysis by Major End-Users

    7 South USA Anti-PD-1 Antibody Landscape Analysis

    • 7.1 South USA Anti-PD-1 Antibody Landscape Analysis by Major Types

    • 7.2 South USA Anti-PD-1 Antibody Landscape Analysis by Major End-Users

    8 Middle West USA Anti-PD-1 Antibody Landscape Analysis

    • 8.1 Middle West USA Anti-PD-1 Antibody Landscape Analysis by Major Types

    • 8.2 Middle West USA Anti-PD-1 Antibody Landscape Analysis by Major End-Users

    9 Northeast USA Anti-PD-1 Antibody Landscape Analysis

    • 9.1 Northeast USA Anti-PD-1 Antibody Landscape Analysis by Major Types

    • 9.2 Northeast USA Anti-PD-1 Antibody Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 BioVision Inc

        • 10.1.1 BioVision Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Bio X Cell

        • 10.2.1 Bio X Cell Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Bristol-Myers Squibb (BMS)

        • 10.3.1 Bristol-Myers Squibb (BMS) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Chugai Pharmaceutical Co, Ltd

        • 10.4.1 Chugai Pharmaceutical Co, Ltd Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Arcus Biosciences

        • 10.5.1 Arcus Biosciences Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Abbvie

        • 10.6.1 Abbvie Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Ono Pharmaceutical Co, Ltd

        • 10.7.1 Ono Pharmaceutical Co, Ltd Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Sino Biological Inc

        • 10.8.1 Sino Biological Inc Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Merck

        • 10.9.1 Merck Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Abcam

        • 10.10.1 Abcam Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 BeiGene

        • 10.11.1 BeiGene Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 TG Therapeutics, Inc

        • 10.12.1 TG Therapeutics, Inc Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 InvivoGen

        • 10.13.1 InvivoGen Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 3SBio Inc

        • 10.14.1 3SBio Inc Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Novartis

        • 10.15.1 Novartis Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Thermo Fisher

        • 10.16.1 Thermo Fisher Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 Lilly

        • 10.17.1 Lilly Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Anti-PD-1 Antibody Market Size and Growth Rate of Monoclonal from 2016 to 2027

    • Figure USA Anti-PD-1 Antibody Market Size and Growth Rate of Polyclonal from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Anti-PD-1 Antibody Market Size and Growth Rate of IHC-P from 2016 to 2027

    • Figure USA Anti-PD-1 Antibody Market Size and Growth Rate of ICC/IF from 2016 to 2027

    • Figure USA Anti-PD-1 Antibody Market Size and Growth Rate of WB from 2016 to 2027

    • Figure USA Anti-PD-1 Antibody Market Size and Growth Rate of Flow Cytometry from 2016 to 2027

    • Figure USA Anti-PD-1 Antibody Market Size and Growth Rate of ELISA from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Anti-PD-1 Antibody Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Anti-PD-1 Antibody Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Anti-PD-1 Antibody Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Anti-PD-1 Antibody Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Anti-PD-1 Antibody Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Anti-PD-1 Antibody

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Anti-PD-1 Antibody by Different Types from 2016 to 2027

    • Table Consumption Share of Anti-PD-1 Antibody by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Monoclonal

    • Figure Market Size and Growth Rate of Polyclonal

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Anti-PD-1 Antibody by Different End-Users from 2016 to 2027

    • Table Consumption Share of Anti-PD-1 Antibody by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of IHC-P

    • Figure Market Size and Growth Rate of ICC/IF

    • Figure Market Size and Growth Rate of WB

    • Figure Market Size and Growth Rate of Flow Cytometry

    • Figure Market Size and Growth Rate of ELISA

    • Table USA Anti-PD-1 Antibody Production by Regions

    • Table USA Anti-PD-1 Antibody Production Share by Regions

    • Figure USA Anti-PD-1 Antibody Production Share by Regions in 2016

    • Figure USA Anti-PD-1 Antibody Production Share by Regions in 2021

    • Figure USA Anti-PD-1 Antibody Production Share by Regions in 2027

    • Table USA Anti-PD-1 Antibody Consumption by Regions

    • Table USA Anti-PD-1 Antibody Consumption Share by Regions

    • Figure USA Anti-PD-1 Antibody Consumption Share by Regions in 2016

    • Figure USA Anti-PD-1 Antibody Consumption Share by Regions in 2021

    • Figure USA Anti-PD-1 Antibody Consumption Share by Regions in 2027

    • Table West USA Anti-PD-1 Antibody Consumption by Types from 2016 to 2027

    • Table West USA Anti-PD-1 Antibody Consumption Share by Types from 2016 to 2027

    • Figure West USA Anti-PD-1 Antibody Consumption Share by Types in 2016

    • Figure West USA Anti-PD-1 Antibody Consumption Share by Types in 2021

    • Figure West USA Anti-PD-1 Antibody Consumption Share by Types in 2027

    • Table West USA Anti-PD-1 Antibody Consumption by End-Users from 2016 to 2027

    • Table West USA Anti-PD-1 Antibody Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Anti-PD-1 Antibody Consumption Share by End-Users in 2016

    • Figure West USA Anti-PD-1 Antibody Consumption Share by End-Users in 2021

    • Figure West USA Anti-PD-1 Antibody Consumption Share by End-Users in 2027

    • Table South USA Anti-PD-1 Antibody Consumption by Types from 2016 to 2027

    • Table South USA Anti-PD-1 Antibody Consumption Share by Types from 2016 to 2027

    • Figure South USA Anti-PD-1 Antibody Consumption Share by Types in 2016

    • Figure South USA Anti-PD-1 Antibody Consumption Share by Types in 2021

    • Figure South USA Anti-PD-1 Antibody Consumption Share by Types in 2027

    • Table South USA Anti-PD-1 Antibody Consumption by End-Users from 2016 to 2027

    • Table South USA Anti-PD-1 Antibody Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Anti-PD-1 Antibody Consumption Share by End-Users in 2016

    • Figure South USA Anti-PD-1 Antibody Consumption Share by End-Users in 2021

    • Figure South USA Anti-PD-1 Antibody Consumption Share by End-Users in 2027

    • Table Middle West USA Anti-PD-1 Antibody Consumption by Types from 2016 to 2027

    • Table Middle West USA Anti-PD-1 Antibody Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Anti-PD-1 Antibody Consumption Share by Types in 2016

    • Figure Middle West USA Anti-PD-1 Antibody Consumption Share by Types in 2021

    • Figure Middle West USA Anti-PD-1 Antibody Consumption Share by Types in 2027

    • Table Middle West USA Anti-PD-1 Antibody Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Anti-PD-1 Antibody Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Anti-PD-1 Antibody Consumption Share by End-Users in 2016

    • Figure Middle West USA Anti-PD-1 Antibody Consumption Share by End-Users in 2021

    • Figure Middle West USA Anti-PD-1 Antibody Consumption Share by End-Users in 2027

    • Table Northeast USA Anti-PD-1 Antibody Consumption by Types from 2016 to 2027

    • Table Northeast USA Anti-PD-1 Antibody Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Anti-PD-1 Antibody Consumption Share by Types in 2016

    • Figure Northeast USA Anti-PD-1 Antibody Consumption Share by Types in 2021

    • Figure Northeast USA Anti-PD-1 Antibody Consumption Share by Types in 2027

    • Table Northeast USA Anti-PD-1 Antibody Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Anti-PD-1 Antibody Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Anti-PD-1 Antibody Consumption Share by End-Users in 2016

    • Figure Northeast USA Anti-PD-1 Antibody Consumption Share by End-Users in 2021

    • Figure Northeast USA Anti-PD-1 Antibody Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of BioVision Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioVision Inc

    • Figure Sales and Growth Rate Analysis of BioVision Inc

    • Figure Revenue and Market Share Analysis of BioVision Inc

    • Table Product and Service Introduction of BioVision Inc

    • Table Company Profile and Development Status of Bio X Cell

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio X Cell

    • Figure Sales and Growth Rate Analysis of Bio X Cell

    • Figure Revenue and Market Share Analysis of Bio X Cell

    • Table Product and Service Introduction of Bio X Cell

    • Table Company Profile and Development Status of Bristol-Myers Squibb (BMS)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb (BMS)

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb (BMS)

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb (BMS)

    • Table Product and Service Introduction of Bristol-Myers Squibb (BMS)

    • Table Company Profile and Development Status of Chugai Pharmaceutical Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chugai Pharmaceutical Co, Ltd

    • Figure Sales and Growth Rate Analysis of Chugai Pharmaceutical Co, Ltd

    • Figure Revenue and Market Share Analysis of Chugai Pharmaceutical Co, Ltd

    • Table Product and Service Introduction of Chugai Pharmaceutical Co, Ltd

    • Table Company Profile and Development Status of Arcus Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arcus Biosciences

    • Figure Sales and Growth Rate Analysis of Arcus Biosciences

    • Figure Revenue and Market Share Analysis of Arcus Biosciences

    • Table Product and Service Introduction of Arcus Biosciences

    • Table Company Profile and Development Status of Abbvie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie

    • Figure Sales and Growth Rate Analysis of Abbvie

    • Figure Revenue and Market Share Analysis of Abbvie

    • Table Product and Service Introduction of Abbvie

    • Table Company Profile and Development Status of Ono Pharmaceutical Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ono Pharmaceutical Co, Ltd

    • Figure Sales and Growth Rate Analysis of Ono Pharmaceutical Co, Ltd

    • Figure Revenue and Market Share Analysis of Ono Pharmaceutical Co, Ltd

    • Table Product and Service Introduction of Ono Pharmaceutical Co, Ltd

    • Table Company Profile and Development Status of Sino Biological Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sino Biological Inc

    • Figure Sales and Growth Rate Analysis of Sino Biological Inc

    • Figure Revenue and Market Share Analysis of Sino Biological Inc

    • Table Product and Service Introduction of Sino Biological Inc

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Abcam

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abcam

    • Figure Sales and Growth Rate Analysis of Abcam

    • Figure Revenue and Market Share Analysis of Abcam

    • Table Product and Service Introduction of Abcam

    • Table Company Profile and Development Status of BeiGene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BeiGene

    • Figure Sales and Growth Rate Analysis of BeiGene

    • Figure Revenue and Market Share Analysis of BeiGene

    • Table Product and Service Introduction of BeiGene

    • Table Company Profile and Development Status of TG Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TG Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of TG Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of TG Therapeutics, Inc

    • Table Product and Service Introduction of TG Therapeutics, Inc

    • Table Company Profile and Development Status of InvivoGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of InvivoGen

    • Figure Sales and Growth Rate Analysis of InvivoGen

    • Figure Revenue and Market Share Analysis of InvivoGen

    • Table Product and Service Introduction of InvivoGen

    • Table Company Profile and Development Status of 3SBio Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3SBio Inc

    • Figure Sales and Growth Rate Analysis of 3SBio Inc

    • Figure Revenue and Market Share Analysis of 3SBio Inc

    • Table Product and Service Introduction of 3SBio Inc

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Thermo Fisher

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher

    • Figure Sales and Growth Rate Analysis of Thermo Fisher

    • Figure Revenue and Market Share Analysis of Thermo Fisher

    • Table Product and Service Introduction of Thermo Fisher

    • Table Company Profile and Development Status of Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lilly

    • Figure Sales and Growth Rate Analysis of Lilly

    • Figure Revenue and Market Share Analysis of Lilly

    • Table Product and Service Introduction of Lilly


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.